immunotherapy

US FDA grants orphan drug designation to oNKord from Glycostem for multiple myeloma

Read more

Bristol Myers Squibb clinches acquisition of Forbius

Read more

Gilead and Jounce Therapeutics sign exclusive license pact for novel immunotherapy program

Read more

Bristol Myers Squibb to acquire Forbius

Read more

Researchers develop technology to see inside cells

Read more

Cancer CART therapy: What are the benefits and stakes?

Read more

Study reveals immunotherapy after chemotherapy slows metastatic bladder cancer

Read more

Virtual Bio Pharma Conclave 2020 – Accelerating Biopharma Innovation | 21st April 2020

Read more

Roche’s Atezolizumab receives DCGI approval for small cell lung cancer treatment in India

Read more

Researchers develop effective nano-vaccine for melanoma

Read more